GS-441524 injection has garnered significant attention in the veterinary world for its promising potential in treating feline infectious peritonitis (FIP), a disease that has long challenged veterinarians and cat owners alike. To truly appreciate the effectiveness of GS-441524, it is essential to delve deeper into its molecular structure, as understanding its chemical makeup helps explain how it functions within the body. This article will explore the intricate details of GS-441524's molecular structure, examine its unique chemical properties, and provide a comparison to similar antiviral compounds. Through this analysis, readers will gain valuable insights into why GS-441524 stands out as a breakthrough treatment for FIP.
We provide GS-441524 injection, please refer to the following website for detailed specifications and product information.
Product:https://www.bloomtechz.com/oem-odm/injection/gs-441524-injection.html
 |
1.General Specification(in stock) (1)Injection 20mg, 6ml; 30mg,8ml; 40mg,10ml (2)Tablet 25/45/60/70mg (3)API(Pure powder) (4)Pill press machine https://www.achievechem.com/pill-press 2.Customization: We will negotiate individually, OEM/ODM, No brand, for secience researching only. Internal Code: BM-3-001 GS-441524 CAS 1191237-69-0 Analysis: HPLC, LC-MS, HNMR Technology support: R&D Dept.-4 |
How GS-441524's structure mimics adenosine nucleotides?
GS-441524 is a nucleoside analog, which means its structure closely resembles natural nucleosides found in our bodies. Specifically, it mimics adenosine, one of the building blocks of DNA and RNA.
The core components of GS-441524
At its core, GS-441524 consists of a modified sugar ring (ribose) connected to a purine base (adenine). This structural similarity to adenosine is what allows it to interact with cellular machinery and exert its antiviral effects.
The key modifications in GS-441524 include:
A cyano group (-CN) at the 1' position of the ribose ring
A methyl group (-CH3) at the 2' position
A hydroxyl group (-OH) at the 3' position
These modifications are crucial for the compound's ability to inhibit viral replication without being immediately broken down by cellular enzymes.
Structural features that enhance cellular uptake
The molecular structure of GS-441524 includes several features that enhance its cellular uptake and bioavailability:
Lipophilic regions that allow it to pass through cell membranes
Hydrogen bond donors and acceptors that facilitate interactions with cellular transporters
A relatively small molecular size that aids in diffusion across biological barriers
These structural elements combine to make GS-441524 injection an effective treatment option, allowing the drug to reach its intended targets within infected cells.
Chemical properties that make GS-441524 effective against FIP
The efficacy of GS-441524 against feline infectious peritonitis is largely due to its unique chemical properties, which stem directly from its molecular structure.
GS-441524 exhibits moderate water solubility, which is crucial for its formulation as an injectable solution. This solubility profile also contributes to its bioavailability, allowing it to be distributed throughout the body and reach infected tissues.
The structural modifications in GS-441524 confer a degree of metabolic stability. This means the compound can persist in the body long enough to exert its antiviral effects before being broken down and eliminated.
Perhaps the most critical chemical property of GS-441524 is its ability to inhibit viral RNA-dependent RNA polymerase. This enzyme is essential for viral replication, and by interfering with its function, GS 441524 drug effectively halts the spread of the virus within the host.
The mechanism of action involves:
Incorporation of GS-441524 into the growing viral RNA chain
Premature chain termination due to the presence of the cyano group
Disruption of the virus's ability to produce functional copies of itself
Another crucial property of GS-441524 is its relatively low cytotoxicity to mammalian cells. This selectivity is due to the compound's preferential interaction with viral enzymes over host cell enzymes, minimizing potential side effects.
Comparison of GS-441524 to Remdesivir's molecular structure
GS-441524 and Remdesivir are closely related compounds, with Remdesivir being a prodrug of GS-441524. Understanding the structural differences between these two molecules can provide insights into their respective roles in antiviral therapy.
Key structural differences
The primary difference between GS-441524 and Remdesivir lies in the presence of a phosphate group in Remdesivir. Specifically:
Remdesivir has a phosphoramidate group at the 5' position of the ribose ring
GS-441524 lacks this phosphate group, having a simple hydroxyl group instead
This phosphate group in Remdesivir is designed to improve cellular uptake and facilitate the intracellular conversion to the active form, which is essentially GS-441524 triphosphate.
Implications for drug delivery and efficacy
The structural differences between GS-441524 and Remdesivir have several implications:
Remdesivir's phosphate group allows for more efficient cellular uptake in some tissues
GS-441524 may have better penetration into certain tissues, such as the central nervous system
The simpler structure of GS-441524 may contribute to its stability and ease of formulation
These structural nuances explain why GS 441524 drug has shown promise in treating FIP, where tissue penetration and stability are crucial factors.
Potential for synergistic effects
The structural relationship between GS-441524 and Remdesivir raises the possibility of potential synergistic effects when used in combination. While this approach hasn't been extensively studied in veterinary medicine, it represents an intriguing area for future research.
Some potential benefits of a combination approach could include:
Enhanced overall antiviral activity
Improved tissue distribution and penetration
Reduced likelihood of viral resistance development
As research in this area continues, we may see novel treatment strategies emerging that leverage the unique structural properties of both compounds.
Conclusion
The molecular structure of GS-441524 is a testament to the power of rational drug design. Its carefully crafted arrangement of atoms allows it to mimic natural nucleosides, inhibit viral replication, and maintain stability within the body. These structural features, combined with its chemical properties, make GS-441524 injection a potent weapon against feline infectious peritonitis.
As our understanding of this remarkable compound continues to grow, we may uncover even more diverse applications and further refine its use in veterinary medicine, enhancing its effectiveness and safety. The journey of GS-441524, from its molecular blueprint to becoming a life-saving treatment for feline infectious peritonitis, exemplifies the incredible potential and advancements made possible by modern pharmaceutical science. This progress not only offers hope to countless cats and their owners but also highlights the importance of ongoing research and innovation in developing targeted therapies.
For pharmaceutical companies, polymer and plastics manufacturers, and those in the specialty chemicals industry seeking high-quality, GMP-certified chemical products, Shaanxi BLOOM TECH Co., Ltd. is your trusted partner. With our state-of-the-art 100,000 square meter production site and expertise in complex chemical reactions and purification techniques, we're equipped to meet your specific needs. Whether you require bulk quantities for long-term contracts or specialized chemicals for your processes, we invite you to explore how our products can enhance your operations. To learn more about our offerings, including GS-441524 and related compounds, please reach out to us at Sales@bloomtechz.com. Let's collaborate to drive innovation in your industry.
References
1. Murphy, B. G., et al. (2020). "The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies." Veterinary Microbiology, 219: 108477.
2. Pedersen, N. C., et al. (2019). "Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis." Journal of Feline Medicine and Surgery, 21(4): 271-281.
3. Gordon, C. J., et al. (2020). "Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency." Journal of Biological Chemistry, 295(20): 6785-6797.
4. Yan, V. C., & Muller, F. L. (2020). "Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment." ACS Medicinal Chemistry Letters, 11(7): 1361-1366.